Drug Type Therapeutic vaccine, mRNA vaccine |
Synonyms- |
Target |
Action modulators, stimulants |
Mechanism CLDN6 modulators(Claudin 6 modulators), Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
CLDN6-positive Solid Tumors | Phase 1 | Australia | 16 Sep 2020 | |
CLDN6-positive Solid Tumors | Phase 1 | Germany | 16 Sep 2020 | |
CLDN6-positive Solid Tumors | Phase 1 | Netherlands | 16 Sep 2020 | |
CLDN6-positive Solid Tumors | Phase 1 | Sweden | 16 Sep 2020 | |
Germ Cell and Embryonal Neoplasms | Phase 1 | Australia | 16 Sep 2020 | |
Germ Cell and Embryonal Neoplasms | Phase 1 | Germany | 16 Sep 2020 | |
Germ Cell and Embryonal Neoplasms | Phase 1 | Netherlands | 16 Sep 2020 | |
Germ Cell and Embryonal Neoplasms | Phase 1 | Sweden | 16 Sep 2020 | |
Ovarian Cancer | Phase 1 | Australia | 16 Sep 2020 | |
Ovarian Cancer | Phase 1 | Germany | 16 Sep 2020 |
Phase 1 | 59 | mkupaveuxt(xerorqgixr) = including related to LD, occurred in 52 pts (88%). wfwuvhagpc (piiumjalpq ) View more | Positive | 15 Sep 2024 | |||